SCHEMBL5370546

SCHEMBL5370546

Cc1cc(C)cc(COc2ccc(N)cc2)c1

nearest known ligand 0.74

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.65
MAOB P27338 9/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
MAPT P10636 2/20 0.60
GAA P10253 1/20 0.60
MAOA P21397 1/20 0.60
RAB9A P51151 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
APP P05067 1/20 0.56
ALDH1A1 P00352 2/20 0.53
TDP1 Q9NUW8 2/20 0.52
TSHR P16473 1/20 0.52
HDAC8 Q9BY41 1/20 0.47
TEAD4 Q15561 1/20 0.47
PRSS1 P07477 1/20 0.46
PRSS2 P07478 1/20 0.46
PRSS3 P35030 1/20 0.46
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13886605 0.85 MAOB (0.60) PARP10MAOB
SCHEMBL22874550 0.85 MAOB (0.66) MAOBSMN1; SMN2MAPTGAAMAOA
SCHEMBL11096427 0.84 MAOB (0.67) PARP10MAOBSMN1; SMN2MAPTGAA
SCHEMBL3762704 0.83 MAOB (0.55) PARP10MAOBSMN1; SMN2MAPTGAA
SCHEMBL9946090 0.83 PARP10 (0.55) PARP10MAOBMAOARAB9AL3MBTL1
SCHEMBL3439660 0.82 PARP10 (0.58) PARP10MAOBSMN1; SMN2MAPTRAB9A
SCHEMBL28567068 0.82 PARP10 (0.62) PARP10MAOBSMN1; SMN2MAPTMAOA
SCHEMBL23566127 0.81 MAOB (0.61) PARP10MAOBPRSS1PRSS2PRSS3
SCHEMBL5121663 0.81 MAOB (0.80) MAOBSMN1; SMN2MAPTGAAMAOA
SCHEMBL14456118 0.81 PARP10 (0.55) PARP10MAOBSMN1; SMN2MAOATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
CN-1930121-A Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER PROD INC (US) 2007-03-14 CN disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD PARP10 798/4885MAOB 4263/4885SMN1; SMN2 3404/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD PARP10 836/4885MAOB 4396/4885SMN1; SMN2 3296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.